Last quarter (Q4 2022), Access Intelligence's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Access Intelligence's net income was $―. See Access Intelligence’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Nov 22	Nov 21	Nov 20	Nov 19	Nov 18
Total Revenue	$ ―	$ 65.71M	$ 33.30M	$ 19.07M	$ 13.43M	$ 8.89M
Cost of Revenue	$ ―	$ 15.91M	$ 8.24M	$ 5.31M	$ 3.40M	$ 2.67M
Gross Profit	$ ―	$ 49.80M	$ 25.05M	$ 13.76M	$ 10.03M	$ 6.21M
Operating Expense	$ ―	$ 56.85M	$ 30.32M	$ 16.49M	$ 11.20M	$ 7.08M
Operating Income	$ ―	$ -7.06M	$ -5.27M	$ -2.74M	$ -1.17M	$ -862.00K
Net Non Operating Interest Income Expense	$ ―	$ -281.00K	$ 330.00K	$ 371.00K	$ 93.00K	$ 160.00K
Other Income Expense	$ ―	$ 254.00K	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ ―	$ -7.49M	$ -9.56M	$ -5.75M	$ -2.89M	$ -1.72M
Tax Provision	$ ―	$ -3.29M	$ -842.00K	$ -660.00K	$ -734.00K	$ -362.00K
Earnings From Equity Interest Net Of Tax	$ ―	$ -254.00K	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -4.19M	$ -8.71M	$ -5.09M	$ -2.16M	$ -1.51M
Basic EPS	$ ―	$ -0.03	$ ―	$ ―	$ ―	$ ―
Diluted EPS	$ ―	$ -0.03	$ ―	$ ―	$ ―	$ ―
Basic Average Shares	$ ―	$ 127.64M	$ ―	$ ―	$ ―	$ ―
Diluted Average Shares	$ ―	$ 127.64M	$ ―	$ ―	$ ―	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ 72.77M	$ -38.56M	$ -21.81M	$ -14.60M	$ -9.75M
Net Income From Continuing And Discontinued Operation	$ ―	$ -4.19M	$ -8.71M	$ -5.09M	$ -2.16M	$ -1.51M
Normalized Income	$ ―	$ -10.78M	$ -6.67M	$ -3.93M	$ -2.20M	$ -1.61M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ ―	$ -7.19M	$ -9.21M	$ -5.37M	$ -2.80M	$ -1.56M
EBITDA	$ ―	$ -249.00K	$ -9.21M	$ -5.37M	$ -2.80M	$ -1.56M

Currency in USD

Access Intelligence Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing